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Bordetella pertussis is a strictly human pathogen causing the respiratory infectious disease called 22 
whooping cough or pertussis. B. pertussis adaptation to acellular pertussis vaccine pressure was has 23 
been recently repeatedly highlighted, but recent data indicate that adaptation of circulating strains 24 
started already in the era of the whole cell pertussis vaccine (wP) use. We sequenced the genomes of 25 
five B. pertussis wP vaccine strains isolated in the former Czechoslovakia in the pre-wP (1954 - 1957) 26 
and early wP use era (1958 - 1965) eras, when only limited population travel into and out of the 27 
country was possible. Four isolates exhibit a similar genome organization and form a distinct 28 
phylogenetic cluster with a geographic signature. The fifth strain is rather distinct, both in genome 29 
organization and SNP-based phylogeny. Surprisingly, despite isolation of this strain before 1966, its 30 
closest sequenced relative appears to be a recent isolate from the US. On the genome content level, 31 
the five vaccine strains contained both new and already described regions of difference. One of the 32 
new regions contains duplicated genes potentially associated with transport across the membrane. 33 
The prevalence of this region in recent isolates indicates that its spread might be associated with 34 
selective advantage leading to increased strain fitness. 35 
  36 






































































Bordetella pertussis, the etiological agent of whooping cough (pertussis), is a strictly human Gram-39 
negative bacterium infecting the respiratory tract (Cherry, 2010). Despite massive world-wide 40 
vaccination programs, pertussis remains the least-controlled vaccine-preventable infectious disease 41 
and it is a major cause of infant morbidity and mortality globally (WHO, 2006). As in many other 42 
countries, prior to introduction of the whole cell-based pertussis vaccine (wP), pertussis was the 43 
major cause of infant mortality in the former Czechoslovakia. The morbidity due to pertussis steeply 44 
declined after the compulsory vaccination was introduced in 1958 (Vysoka-Burianova et al., 1976). As 45 
in other countries with high vaccination coverage, the incidence of pertussis in the Czechoslovakia 46 
and later on in the Czech Republic started to rise progressively since the 1990s (Raguckas et al., 2007, 47 
Fabianova et al., 2010, Sealey et al., 2016) and this trend accelerated strongly upon switch to 48 
acellular pertussis subunit vaccine  use in 2007 (Chlibek et al., 2017).  49 
While several factors are contributing to pertussis resurgence in the most developed countries, the 50 
two prominent ones are the incomplete and short-lived immunity induced by current aP vaccines 51 
and the genetic changes in circulating B. pertussis strains that lead to escape from immunity by 52 
antigenic variation (Mooi et al., 2014, Burdin et al., 2017). However, adaptive mutations occurred 53 
already in the wP era, suggesting that the major driving force of B. pertussis adaptation is vaccination 54 
as such (Bart et al., 2014). B. pertussis is generally considered to be a genetically monomorphic 55 
pathogen (King et al., 2010, Mooi, 2010) with rather limited extent of sequence variation within the 56 
global population (Bart et al., 2014). Nevertheless, B. pertussis possesses an efficient mechanism of 57 
genome structure diversification due to the presence of almost 250 copies of the insertion sequence 58 
IS481 in its genome. These mobile elements allow for intragenomic recombination and excision 59 
and/or insertion of the flanked genome regions, leading to genome decay (Parkhill et al., 2003, 60 
Cummings et al., 2004), genome rearrangements (Bowden et al., 2016, Weigand et al., 2017) and 61 
gene expression alterations (Brinig et al., 2006). Recently, we showed that insertion elements 62 
significantly affect the global gene expression profile in B. pertussis (Amman et al., 2018). Apparently, 63 
B. pertussis adaptation goes beyond the changes in the genes coding for antigens that are present in 64 
the acellular vaccine and involves also other virulence-associated genes and the genes coding for 65 
surface-exposed proteins (Bart et al., 2014). To understand how these vaccination-induced 66 
adaptation changes contributed to the current re-emergence of whooping cough, it is important to 67 
analyze genomes of strains from the pre-vaccine era. At present, there are over 1000 B. pertussis 68 
genome sequences deposited in Genbank and JGI GOLD databases (Mukherjee et al., 2017). cClose to 69 




































































350 of them are completely assembled, of which B. pertussis genomic sequences deposited at the 70 
GenBank database, of which 330 are the genome sequences of the isolates from the aP vaccine era 71 
(since 1990s). In this study we thus sequenced and de novo assembled genomes of five historical B. 72 
pertussis strains that were collected in the former Czechoslovakia between 1954 and 1965. The very 73 
same strains were used for the formulation of the DTwP vaccine Alditepera, produced by the 74 
Institute of Sera and Vaccines in Prague (Pekarek & Rezabek, 1959, Pekarek & Rezabek, 1959). These 75 
strains were not extensively passaged under laboratory conditions and represent a unique set of 76 
isolates from the pre-wP vaccine (1954-1957) and early wP vaccine era (1958-1965). The content and 77 
organization of the genome of these strains was compared to that of other vaccine strains and recent 78 
clinical isolates.  79 
GENOME SEQUENCING AND ANNOTATION 80 
Genomes were sequenced using Illumina MiSeq (paired-end sequencing protocol) and PacBio RSII 81 
platforms. Illumina data is deposited under the project PRJEB4543 in Genbank. PacBio reads were 82 
assembled using HGAP SMRT Portal protocol and Illumina data was used to further polish the 83 
assemblies with Pilon software (Walker et al., 2014). All genomes were de novo assembled into single 84 
contigs (Supplementary table 1), deposited in GenBank under accession numbers ERS2367611-85 
ERS2367615 and annotated using Prokka software (Seemann, 2014).  86 
 87 
PHYLOGENETIC ANALYSIS 88 
Genomic analysis revealed that all Czech vaccine strains belong to ptxP1 lineage (carry pertussis toxin 89 
promoter type 1). B. pertussis strains from ptxP1 lineage form a phylogenetic cluster separate from 90 
ptxP3 strains which emerged in the last 25-30 years (Bart et al., 2014, Weigand et al., 2017). 91 
Therefore, to put genomic sequences of the Czech vaccine strains into broader context with 92 
previously completely sequenced ptxP1 and ptxP2 strains of B. pertussis, we performed SNP-based 93 
phylogenetic analysis using the kSNP3.0 program with k of 23 and maximum parsimony method 94 
(Gardner et al., 2015). In total we analyzed 19 ptxP1 and 4 ptxP2 strains, which were isolated from 95 
various geographic locations (USA, China, Japan, UK, Netherlands) from 1935 to 2012 96 
(Supplementary Table 1). Phylogenetic analysis based on the 851 detected SNPs divided the strains 97 
into six major clusters (Figure 1A). Most of the recent isolates (isolated in 2000-2012) containing 98 
ptxP1 allele clustered separately from the old ptxP1 isolates (isolated in 1935-1965). Surprisingly, one 99 
of the old Czech strains, VS67, clustered together with the strain E945, which was isolated in the USA 100 
in 2005. The other four Czech strains formed a distinct cluster (cluster 4), separated from the other 101 
strains by six synonymous, six non-synonymous and three intergenic SNPs (Supplementary Table 2).  102 
 103 




































































GENOME ORGANIZATION 104 
The sequenced genomes were aligned by progressiveMauve algorithm with default parameters 105 
(Darling et al., 2010). Alignment revealed that when compared to the reference strain Tohama I, all 106 
genomes contain large-scale structural rearrangements (Figure 1B). According to the genome 107 
organization, the strains could be classified into three groups. One group contains three strains: 108 
VS377, VS401 and VS366. Strain VS393 differs from this group by a single large inversion, which, 109 
among other genes, contains fha/fim and type III secretion system loci. VS67 differs from the other 110 
four strains by two additional large-scale inversions. In order to determine whether genome 111 
organization observed in the Czech strains can be also found among other already characterized 112 
strains, we have extracted and compared the permutation matrices from the Mauve alignment 113 
utilizing scripts published previously (Weigand et al., 2017). This analysis revealed that Czech strains 114 
have a unique genome organization that has not been found so far in the other ptxP1 and ptxP2 115 
strains (data not shown).  116 
 117 
REGIONS OF DIFFERENCE   118 
Mauve output was used to extract genome regions differentially present among the strains. In total 119 
eight such regions of difference were identified among the studied Czech strains and Tohama I (Table 120 
1, Supplementary Figure 1). All RDs are either directly or in close proximity flanked by IS481 elements 121 
which indicates the mobile nature of the RDs.  122 
Majority of the identified GRs have been described previously and for them we kept the previously 123 
established designation (Brinig et al., 2006, Bart et al., 2010). Two of the newly reported RDs were 124 
consecutively named RD30 and RD31 (Table 1). RD30, which is duplicated in VS67, contains genes, 125 
which code for the MFS transporter and a putative membrane protein (BP2451 and BP2452). It is 126 
possible that the duplicated region allows for enhanced transport of the cargo across the membrane. 127 
RD31 consists of 5 genes, but the only gene with assigned function is BP0894 coding for mannose-6-128 
phosphate isomerase.  129 
 130 
PREVALENCE OF RDs 131 
Analysis of the association of the identified RDs with other B. pertussis strains showed that in many 132 
cases the distinct distribution of RDs among the strains correlated with their phylogenetic 133 
assignment (Supplementary Table 3). For instance, RD3 and RD5 are associated with pre-aP era B. 134 
pertussis strains from phylogenetic clusters 5 and 6. RD3 is also present in the Czech strains 135 
comprising cluster 4. In contrast, duplication of RD30 is prevalent in aP-era strains from the 136 
phylogenetic cluster 3. This suggests that the duplication might provide the currently circulating 137 
strains with a selective fitness advantage. The distribution of RD22-24 and RD26 among the strains is 138 




































































very similar, suggesting that the functions encoded within these loci might be linked. These GRs are 139 
found in almost all strains except for the cluster 6. RD29 and RD31 are missing in the Czech vaccine 140 
strains VS366 and VS393, respectively, indicating that the loss of these regions might have not 141 
conferred any advantage to these strains which possibly prevented their further spread.  142 
 143 
DISCUSSION 144 
In this study we conducted a comprehensive analysis of the genomes of five B. pertussis strains that 145 
were collected from 1954 to 1965 in the former Czechoslovakia at times when population travel into 146 
and out of the country was very limited. These representative isolates were later used for the 147 
development of the local wP vaccine. In contrast to the Japanese vaccine strain Tohama I, the Czech 148 
vaccine strains did not undergo massive passaging under laboratory conditions. This is the first study 149 
on Czech B. pertussis vaccine strains and one of the very few providing complete genome assemblies 150 
for the strains from the pre-wP vaccine or early wP use era. De novo sequencing of the genomes 151 
revealed that all Czech strains contain large-scale genome structural rearrangements compared to 152 
the reference strain Tohama I. 153 
SNP-based phylogeny revealed that four of the strains form a separate cluster distinct from other 154 
so far analyzed strains, suggesting that at the time of their isolation the geographic factors played a 155 
significant role. It is tempting to speculate that following massive immunization by the wP vaccine, 156 
these strains disappeared from the population and did not spread globally. On the other hand, the 157 
fifth Czech strain V67 clusters together with a recent US isolate suggesting that it belongs to a 158 
lineage the descendants of which may still circulate within immunized population.  159 
In agreement with SNP-based phylogenetic analysis, Czech B. pertussis strains exhibit a genome 160 
organization pattern that distinguishes them from other ptxP1 and ptxP2 strains, and contain 161 
some new and some previously reported regions of difference (Brinig et al., 2006, Bart et al., 162 
2010). Loss of RD3 and/or RD5 is characteristic of B. pertussis strains isolated from other 163 
countries during the early wP use period (Kallonen et al., 2011). Accordingly, RD5 was absent 164 
from all Czech strains and RD3 was lost from VS67 strain. Four of the RDs (RD22-24 and RD26) 165 
absent in Tohama I, are present in the Czech strains thereby supporting earlier reports which 166 
demonstrate the presence of these loci in the majority of older European B. pertussis isolates and 167 
vaccine strains (Kallonen et al., 2011).  168 
To conclude, our study suggests that the analysis of strains from pre-vaccine era is of high 169 
importance for our understanding of B. pertussis evolution in the light of pertussis resurgence. 170 
The impact of the various SNPs, RDs and genome re-arrangements on the physiological fitness 171 
and pathogenicity of each particular B. pertussis isolate, however, remains to be determined.  172 
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Table 1. Distribution of regions of difference among Czech vaccine strains 
 
RD Presence/Absence in strain Start, RD Stop, RD Reference 
RD3 Absent in VS67 BP0911 BP0937 Brinig et al., 2006 
RD5 Present only in Tohama I BP1136 BP1141 Brinig et al., 2006 
RD22 Absent only in Tohama I BB0541 BB0534 Brinig et al., 2006 
RD23 Absent only in Tohama I BB0917 BB0921 Bart et al., 2010 
RD24 Absent only in Tohama I BB1140 BB1158 Brinig et al., 2006 
RD26 Absent only in Tohama I BB4888 BB4880 Brinig et al., 2006 
RD29 Absent only in VS366 BP2820 BP2832 King et al., 2008 
RD30 Repeated 2x in VS67 BP2452 BP2451 This study 
RD31 Absent only in VS393 BP0892 BP0896 This study 
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Supplementary table 1. Strains used in this study 
Strain Genbank Acces. No. Country Year ptxP Reference Additional remarks 
B199 CP022361 USA: PA 1935 ptxp2 Unpublished 
 B203 CP012128 USA: MI 1939 ptxP2 Weigand et al., 2016) Sanofi-Pasteur MSD, strain 10536 
B202 CP016338 USA: PA 1946 ptxP1 Weigand et al., 2016 Lederle Laboratories, strain 134 
J042 CP019869 USA 1947 ptxP1 Unpublished 
 J043 CP016887 USA 1947 ptxP1 Unpublished 
 C393 CP010963 China 1951 ptxP1 Bowden et al., 2016 CS, Chinese vaccine reference 
E476 CP010964 Japan 1954 ptxP1 Bowden et al., 2016 Tohama I, GlaxoSmithKline vaccine reference 
B201 CP013075 USA: IN 1955 ptxP1 Weigand et al., 2017 
 B227 CP013076 UK 1967 ptxP1 Weigand et al., 2017 
 B226 CP016957 UK 1967 ptxP1 Unpublished 
 B1920 CP009752 Netherlands 2000 ptxP1 Bart et al., 2014 
 VA-UT25Sm1 CP015771 USA: VATX 20011977 ptxP1 Unpublished 
 E976 CP011175 USA: NY 2005 ptxP1 Weigand et al., 2017 
 E945 CP016956 USA: CA 2005 ptxP1 Unpublished 
 H375 CP010961 USA: CA 2010 ptxP1 Bowden et al., 2016 
 H740 CP011190 USA: GA 2011 ptxP1 Weigand et al., 2017 
 I344 CP011255 USA: MN 2012 ptxP1 Weigand et al., 2017 
 Bp137 CP010323 USA ND ptxP2 Akamatsu et al., 2015 Vaccine strain in Latin America 
J448 CP017405 ND ND ptxP1 Weigand et al., 2016 Reference strain from Serum Institute of India 
J445 CP017402 ND ND ptxP1 Weigand et al., 2016 Reference strain from Serum Institute of India 
J447 CP017404 ND ND ptxP1 Weigand et al., 2016 Reference strain from Serum Institute of India 
J446 CP017403 ND ND ptxP2 Weigand et al., 2016 Reference strain from Serum Institute of India 
Pelita III CP019957 Japan ND ptxP1 Unpublished Indonesian reference strain, P.T. Bio Farma Indonesia 
VS67 ERZ500380 Czech Republic before 1966 ptxP1 This study 
 VS393 ERZ500382 Czech Republic before 1966 ptxP1 This study 
 VS401 ERZ500384 Czech Republic 1954 ptxP1 This study 
 VS377 ERZ500383 Czech Republic before 1966 ptxP1 This study 
 VS366 ERZ500381 Czech Republic 1957 ptxP1 This study 
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Supplementary table 2. List of SNPs distinguishing the cluster 4 strains 
SNP No. Position Allele Intergenic/Synonymous/Non-synonymous Annotation Gene in E476 (Tohama I) 
1 3967296 G/A Synonymous cytochrome oxidase subunit I RD16_18905 
2 3310990 G/A Synonymous molybdate ABC transporter substrate-binding protein RD16_15605 
3 1684734 G/A Intergenic histidine kinase upstream of RD16_07985 
4 1482030 C/T Synonymous ATP synthase RD16_06985 
5 1645729 G/A Non-synonymous (A/T) aminopeptidase RD16_07800 
6 2176522 C/T Intergenic MarR family transcriptional regulator upstream of RD16_10235 
7 1921439 G/A Synonymous hypothetical protein RD16_09100 
8 760046 C/T Non-synonymous (G/D) DNA methylase RD16_03690 
9 3477892 C/T Non-synonymous (A/T) ABC transporter substrate-binding protein RD16_16365 
10 33773 G/A Non-synonymous (A/V) 2-methyl citrate dehydratase RD16_00170 
11 371766 A/G Intergenic glutamate dehydrogenase Upstream of RD16_01860 
12 1336320 C/T Non-synonymous (E/K) hypothetical protein pseudogene 
13 2157160 G/A Synonymous sodium transporter pseudogene 
14 4018189 C/T Non-synonymous (G/D) AraC family transcriptional regulator RD16_19175 
15 2401358 C/T Synonymous chemotaxis protein RD16_11360 
 
 
































































Supplementary table 3. Prevalence of identified genomic regions in strains used in this study 
Strain 
Genbank 
Acces. No. RD3 RD30 RD29 RD31 RD24 
RD22/ 
RD26 RD23 RD5 
B199 CP022361 + 
 
+ + + + + + 
B203 CP012128 + 
 
+ + + + + + 
B202 CP016338 
 
+ + + + + + 
 J042 CP019869 + 
 
+ + 
   
+ 
J043 CP016887 + 
 
+ + 
   
+ 
C393 (CS) CP010963 + 
 
+ + + +  
 
+ 







+ + + + + + 
 B227 CP013076 
 
+ + + + + + 
 B226 CP016957 
 
+ + + + + + 
 B1920 CP009752 
 
+ + + 
 
+ + 
 VA-UT25Sm1 CP015771 + + + + + + + 
 E976 CP011175 
 
+ + + + + + 
 E945 CP016956 
 
+ + + + + + 
 H375 CP010961 
 
+ + + + + + 
 H740 CP011190 
 
+ + + + + + 
 I344 CP011255 
 
+ + + + + + 
 Bp137 CP010323 + 
 
+ + + + + + 
J448 CP017405 
 
+ + + +  + 
 J445 CP017402 
 
+ + + + + + 
 J447 CP017404 
  
+ + + +  + 
 J446 CP017403 + 
 
+ + + + + + 







+ + + + + + 




+ +  + 
 VS401 ERS2367615 + 
 
+ + + +  + 
 VS377 ERS2367614 + 
 
+ + + +  + 
 VS366 ERS2367612 + 
  
+ + +  + 
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